Key result
Complete haematologic response in cardiac amyloidosis improves myocardial work, and GLS changes strongly predict survival.
Why the study?
Complete haematologic response to treatment for light chain cardiac amyloidosis may improve myocardial function, prompting evaluation of treatment response on echocardiographic myocardial deformation, work, and prognosis.
Does complete haematologic response to treatment improve echocardiographic indices of myocardial work and survival in patients with light chain cardiac amyloidosis?
Cohort (n=61)
Does complete haematologic response to treatment improve echocardiographic indices of myocardial work and survival in patients with light chain cardiac amyloidosis?
Hazard Ratio: 1.404
p-value: p=0.046
Complete haematologic response in light chain cardiac amyloidosis improves left ventricular myocardial work indices, and these improvements independently predict better survival.
Supports serial myocardial work assessment in AL-CA responders; extends GLS-survival link but remains hypothesis-generating.
AIMS: Complete haematologic response to treatment for light chain cardiac amyloidosis (AL-CA) may lead to improvement of myocardial function and better outcomes. We sought to evaluate the effect of response to treatment for AL-CA on echocardiographic indices of myocardial deformation and work and their prognostic significance. METHODS AND RESULTS: Sixty-one patients treated for AL were enrolled and underwent echocardiographic assessment at baseline and at 1 year. Patients were stratified according to haematologic response as complete or not complete responders. A significant reduction in median N-terminal pro-brain natriuretic peptide (NT-proBNP) (2771-1486 pg/mL; P < 0.001) and posterior wall thickness (13-12 mm; P = 0.002) and an increase in global work index (GWI) (1115-1356 mmHg%; P = 0.018) was observed at 1 year. Patients with complete response (CR) had a more pronounced decrease in intraventricular septum thickness (14.2-12.0 mm; P = 0.006), improved global longitudinal strain (GLS) (-11.6 to -13.1%; P for interaction = 0.045), increased global constructive work (1245-1436 mmHg%; P = 0.008), and GWI (926-1250 mmHg%, P = 0.002) compared with non-CR. Furthermore, deltaGLS (ρspearman = 0.35; P < 0.001) and deltaGWI (ρspearman = -0.32; P = 0.02) correlated with delta NT-proBNP. Importantly, patients with GLS and GWI response had a better prognosis (log-rank P = 0.048 and log-rank P = 0.007, respectively). After adjustment for Mayo stage, gender, and response status, deltaGLS [hazard ratio (HR) = 1.404, P = 0.046 per 1% increase] and deltaGWI (HR = 0.996, P = 0.042 per 1mmHg% increase) were independent predictors of survival. CONCLUSION: Complete haematologic response to treatment is associated with improved left ventricular myocardial work indices, and their change is associated with improved survival in AL-CA.
No takes yet. Share an insight, caveat, or question.
Briasoulis et al. (2023) conducted a cohort in Light chain cardiac amyloidosis (AL-CA) (n=61). Complete haematologic response to treatment vs. Not complete responders was evaluated on Survival (per 1% increase in deltaGLS) (HR 1.404, p=0.046). Complete haematologic response in light chain cardiac amyloidosis improved myocardial work indices, and changes in global longitudinal strain independently predicted survival (HR 1.404, P=0.046).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: